China NT Pharma Group Company Limited (1011.HK)

HKD 0.27

(1.89%)

Market Cap (In HKD)

71.3 Million

Revenue (In HKD)

7.36 Million

Net Income (In HKD)

-143.59 Million

Avg. Volume

746.94 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.017-1.4
PE
-
EPS
-
Beta Value
-1.432
ISIN
KYG2114L1059
CUSIP
G2114L105
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Tit Ng
Employee Count
-
Website
https://www.ntpharma.com
Ipo Date
2011-04-20
Details
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.